G01N2333/91051 - CPC Classification Index

ClassID:

170608 ⎘

G01N2333/91051 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.); Acyltransferases (2.3) Acyltransferases other than aminoacyltransferases (general) (2.3.1)

Sub-classes:

G01N2333/91057 » with definite EC number (2.3.1.-) 67

Recent Application in this class:

20240142457

2024-05-02

USE OF CASD1 AS A BIOMARKER OF A CANCER EXPRESSING THE O-ACETYLATED-GD2 GANGLIOSIDE

20220403443

2022-12-22

HIGH-THROUGHPUT ENZYME ASSAY FOR SCREENING ACTIVITY OF ACYLTRANSFERASES

20220298216

2022-09-22

GHRELIN O-ACYLTRANSFERASE (GOAT) IMAGING AGENTS

20220002801

2022-01-06

Inhibitors of alpha-tubulin acetylation for the treatment of pain

20210190794

2021-06-24

COMPOSITIONS AND METHODS FOR PROTEIN DETECTION

20200102365

2020-04-02

GHRELIN O-ACYLTRANSFERASE (GOAT) IMAGING AGENTS

20190024170

2019-01-24

Inhibitors of α-tubulin acetylation for the treatment of pain

20180305758

2018-10-25

Advanced detection of sepsis

20180002752

2018-01-04

Advanced detection of sepsis

#10

20160317626

2016-11-03

Method of reducing accumulation of intracellular tingible body macrophages

#11

20160216268

2016-07-28

SRM/MRM assay for the fatty acid synthase protein

#12

20160040233

2016-02-11

Advanced detection of sepsis

#13

20150355189

2015-12-10

QUANTITATIVE ANALYSIS OF TRANSGENIC PROTEIN 5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE

#14

20150218648

2015-08-06

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS IN BREAST CANCER

#15

20150203851

2015-07-23

INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN PCAF FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES OR FOR THE TREATMENT OF CANCER

#16

20150099270

2015-04-09

METHOD OF SCREENING PHARMACEUTICALS FOR DRUG INTERACTIONS AND NEPHROTOXICITY

#17

20150057334

2015-02-26

USE OF INHIBITORS OF ZDHHC2 ACTIVITY FOR MODULATION OF ADIPOGENESIS

#18

20140302533

2014-10-09

Advanced detection of sepsis

#19

20140212904

2014-07-31

Fluorescence assay for ghrelin O-acyltransferase activity

#20

20140206775

2014-07-24

SRM/MRM assay for the fatty acid synthase protein

#21

20120177661

2012-07-12

HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR

#22

20120165391

2012-06-28

Use of inhibitors of Zdhhc2 activity for modulation of adipogenesis

#23

20120121571

2012-05-17

Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus

#24

20120003233

2012-01-05

Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor

#25

20110190165

2011-08-04

HIGH THROUGHPUT METHODS OF IDENTIFYING NEUTRAL LIPID SYNTHASES

#26

20110118569

2011-05-19

Advanced detection of sepsis

#27

20100285525

2010-11-11

Method of using lipid acyltransferase

#28

20100159478

2010-06-24

Biomarkers for chronic vascular dysfunction

#29

20100074888

2010-03-25

Animal having modification in MGAT2 gene

#30

20100035339

2010-02-11

HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR

#31

20090324575

2009-12-31

Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis

#32

20090298074

2009-12-03

Modulators of ELOVL5 for treating acne or hyperseborrhea

#33

20090269332

2009-10-29

Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor

#34

20090220512

2009-09-03

Genes and polypeptides relating to prostate cancers

#35

20090170141

2009-07-02

Ghrelin o-acyltransferase (GOAT) biochemical assay

#36

20090155241

2009-06-18

Prophylactic/therapeutic agent for cancer

#37

20090023163

2009-01-22

Method of Measuring Enzyme Activity and Method of Evaluating Compound

#38

20080293081

2008-11-27

Fluorescence Polarization Assays for Acetyltransferase/Deacetylase Activity

#39

20070269842

2007-11-22

Method for identifying acetyltransferase substrates

#40

20070269423

2007-11-22

Method of detecting the expression of PPN/MG61 and the use of it

#41

20070166748

2007-07-19

HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR

#42

20070122525

2007-05-31

Method of using lipid acyltransferase

#43

20070026106

2007-02-01

Method of using lipid acyltransferase

#44

20060183210

2006-08-17

Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor

#45

20060148739

2006-07-06

Method of evaluating compound efficacious in treating obesity

#46

20060134752

2006-06-22

Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor

#47

20060078648

2006-04-13

Method of using lipid acyltransferase

#48

20060068462

2006-03-30

Method

#49

20050019851

2005-01-27

Use of VLCFAE for identifying herbicidally active compounds

#50

20050009189

2005-01-13

Use of VLCFAE for identifying herbicidally active compounds